Invion Limited Invion Limited

Invion Limited

IVX

Rank in Stocks #31915
Invion Limited, an Australian clinical-stage life sciences enterprise, is... Invion Limited, an Australian clinical-stage life sciences enterprise, is actively engaged in the research and development of photodynamic therapy (PDT) to address various cancer types. Its flagship offering, IVX-PDT, is a photosensitizer agent being developed to combat skin cancers alongside a range of solid tumors, including those affecting the lungs, prostate, ovaries, and mesothelioma. The company has forged a research and development alliance with the Hudson Institute of Medical Research, jointly pursuing R&D initiatives for its Photosoft technology across a broad spectrum of cancer treatments. Moreover, a dedicated research agreement with the Peter MacCallum Cancer Centre facilitates pre-clinical and in-vitro investigations into Invion's IVX-PDT for ano-genital cancers, such as penile and anal cancers. The firm was established in 2000 and is headquartered in Melbourne, Australia.
Share Price
$0.02266382
Last synced: 2026-11-11
Market Cap
$2.25M
Change (1 day)
-11.51%
Change (1 year)
-54.09%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Invion Limited (IVX)
Operating Margin as of November 2026 TTM: -1,472.22%
According to Invion Limited's latest financial reports, its current operating margin (TTM) is -1,472.22%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Invion Limited from 2006 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -1,472.22% 0.00%
2025 0.00% -100.00%
2024 -153.68% 282.67%
2023 -40.16% -43.05%
2022 -70.52% 4.51%
2021 -67.48% 128.59%
2020 -29.52% -54.48%
2019 -64.85% -50.19%
2018 -130.20% 0.00%
2017 0.00% -100.00%
2016 -4,456.92% -44.32%
2015 -8,004.76% 100.39%
2014 -3,994.55% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
2010 0.00% 0.00%
2009 0.00% 0.00%
2008 0.00% 0.00%
2007 0.00% 0.00%
2006 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
19.69% -100.01%
DE
19.68% -100.01%
DE
13.26% -100.01%
JP
17.08% -100.01%
CH
10.53% -100.01%
IL
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Invion Limited's operating margin

What is Invion Limited's operating margin?

Invion Limited's operating margin is -1,472.22%, as of Nov 2026.

What was Invion Limited's operating margin in 2025?

In 2025, Invion Limited's operating margin was 0.00%, compared with -153.68% in 2024.

How has Invion Limited's operating margin changed since 2020?

From 2020 to 2025, Invion Limited's operating margin was highest in 2025 (0.00%) and lowest in 2024 (-153.68%).

How does Invion Limited's operating margin compare with similar companies?

Invion Limited's operating margin (-1,472.22%) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with 19.69%.